← back to search

Takahiro Karasaki

Cancer Institute (WIA) ·
Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, and Immune cells in cancer.
h-index
28
citations
4,103
works
178
NIH funding
primary concept
Medicine
email

Recent publications

Abstract 6821: The temporal dynamics and molecular impact of clonal hematopoiesis in non-small cell lung cancer
Cancer Research 2026cited by 0position: middledoi
Abstract 6793: Clinico-genomic characteristics of multiple primary cancers in TRACERx
Cancer Research 2026cited by 0position: middledoi
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Nature Medicine 2025cited by 75position: middledoi
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
Nature Cancer 2025cited by 12position: middledoi
Clone copy number diversity is linked to survival in lung cancer
Nature 2025cited by 4position: middledoi
Somatic evolution following cancer treatment in normal tissue
Nature 2025cited by 3position: middledoi
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Nature Communications 2024cited by 25position: middledoi
LBA9 Clinical insights from ultra-sensitive tumour-informed ctDNA tracking across the TRACERx cohort
Annals of Oncology 2024cited by 0position: middledoi
Lung adenocarcinoma promotion by air pollutants
Nature 2023cited by 728position: middledoi
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Nature 2023cited by 327position: middledoi
The evolution of lung cancer and impact of subclonal selection in TRACERx
Nature 2023cited by 300position: middledoi
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Nature 2023cited by 247position: middledoi
The evolution of non-small cell lung cancer metastases in TRACERx
Nature 2023cited by 230position: middledoi
Body composition and lung cancer-associated cachexia in TRACERx
Nature Medicine 2023cited by 123position: middledoi
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
Nature Cancer 2022cited by 111position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Selvaraju Veeriah · University College London Hospitals NHS Foundation Trust3 papers (2024–2026)Nicholas McGranahan · London Cancer3 papers (2024–2026)Ariana Huebner · The Francis Crick Institute3 papers (2025–2026)Charles Swanton · Cancer Evolution and Genome Instability Laboratory3 papers (2024–2026)James R. Black · Department of Health and Human Services2 papers (2024–2026)Alexander M. Frankell · University of Cambridge2 papers (2024–2025)Aino‐Maija Leppä · The Francis Crick Institute2 papers (2026–2026) · 2 papers (2026–2026) · 2 papers (2026–2026)Lydia Liu · University of California, Los Angeles2 papers (2026–2026)Alexandar M. Frankell · Cancer Research UK Cambridge Center2 papers (2026–2026) · 2 papers (2026–2026) · 2 papers (2026–2026)Sophia Ward · The Francis Crick Institute1 papers (2026–2026)Allan Hackshaw · Cancer Research UK1 papers (2025–2025)Olivia Lucas · Singleton Hospital1 papers (2026–2026)Elsa Bernard · Institut Gustave Roussy1 papers (2026–2026)Oriol Pich · The Francis Crick Institute1 papers (2026–2026)Adam J. Mead · National Institute for Health and Care Research1 papers (2026–2026)Maise Al Bakir · The Francis Crick Institute1 papers (2024–2024)